Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Pellucid Marginal Corneal Degeneration Clinical Trials

2 recruiting trials for Pellucid Marginal Corneal Degeneration. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT07124910

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA...

The goal of this clinical trial is to study the effects of an experimental (not Food and Drug Administration (FDA)-approved) treatment called corneal crosslinking (CXL) for...

Sponsor: Woolfson Eye InstituteEnrolling: 48512 locations
RECRUITINGPhase 2NCT04094090

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

Sponsor: Goodman Eye CenterEnrolling: 5001 location